---
title: "Insights into the therapeutic strategies for aging and…"
description: "A 2026 map of the longevity-therapeutics field: senolytics, senomorphics, senoreversion and caloric-restriction mimetics are the leading strategies, with…"
url: "https://magellanlongevity.com/study/aging_therapeutics_2026.md"
canonical: "https://magellanlongevity.com/study/aging_therapeutics_2026.html"
html: "https://magellanlongevity.com/study/aging_therapeutics_2026.html"
type: "study"
study_key: "aging_therapeutics_2026"
journal: "Signal Transduction and Targeted Therapy"
year: 2026
pmid: "42225652"
doi: "10.1038/s41392-026-02662-z"
citations: 1
updated: 2026-09-02
author: "Gabriel Radu, DO"
author_credentials: "Physiatrist (PM&R). NY medical license 275110. NPI 1376861765."
publisher: "Magellan Longevity"
content_format: "markdown"
---

# Insights into the therapeutic strategies for aging and aging-associated diseases

[Home](https://magellanlongevity.com/) › [Research map](https://magellanlongevity.com/longevity-research-map.html) › Insights into the therapeutic strategies for aging and…

**HTML version:** https://magellanlongevity.com/study/aging_therapeutics_2026.html · **In the Magellan app:** https://magellanlongevity.com/#/study/aging_therapeutics_2026

## Citation

| Field | Value |
| --- | --- |
| Journal | Signal Transduction and Targeted Therapy |
| Year | 2026 |
| PMID | [42225652](https://pubmed.ncbi.nlm.nih.gov/42225652/) |
| DOI | [10.1038/s41392-026-02662-z](https://doi.org/10.1038/s41392-026-02662-z) |
| Study key | aging_therapeutics_2026 |

## Takeaway

A 2026 map of the longevity-therapeutics field: senolytics, senomorphics, senoreversion and caloric-restriction mimetics are the leading strategies, with AI accelerating discovery — but human proof remains the gating step.

## The question

Which therapeutic strategies can slow biological aging and reduce the burden of age-related diseases — and how close are they to the clinic?

## Hypothesis

Interventions that target the core hallmarks of aging — cellular senescence, metabolic dysfunction, epigenetic alterations and mitochondrial impairment — can delay aging and lower disease risk, moving medicine toward 'precision longevity.'

## Methods

A comprehensive review systematically summarizing current breakthroughs, clinical landscapes and future directions across the major classes of aging therapeutics, alongside the emerging role of artificial intelligence in discovery.

## Results

The authors group emerging interventions into three senescence-focused strategies — senolytics that eliminate senescent cells (e.g., dasatinib + quercetin), senomorphics that suppress the senescence-associated secretory phenotype (e.g., rapamycin), and senoreversion that rejuvenates cells via epigenetic reprogramming — plus metabolic approaches such as caloric-restriction mimetics (spermidine, α-ketoglutarate, ergothioneine) that enhance mitochondrial function, activate autophagy and extend lifespan and healthspan in preclinical models. AI is highlighted for integrating multiomics data, predicting candidate compounds, identifying biomarkers and personalizing interventions.

## Conclusion

Targeting aging hallmarks holds real promise for delaying aging and alleviating age-related pathology, and the convergence of AI, multitarget strategies and precision medicine signals a transformative era for extending healthspan.

## Limitations

This is a review of largely preclinical evidence. Key challenges remain in target specificity, off-target effects and clinical translation — most interventions are not yet proven to extend healthy lifespan in humans.

## Verbatim from the abstract

> Therapeutic strategies targeting aging hallmarks can delay aging and mitigate disease risk. The convergence of AI, multitarget strategies, and precision medicine signals a transformative era in extending healthspan and combating aging-associated diseases.

## Reference

1. **Insights into the therapeutic strategies for aging and aging-associated diseases**
   Signal Transduction and Targeted Therapy 2026 · [PMID 42225652](https://pubmed.ncbi.nlm.nih.gov/42225652/) · [DOI 10.1038/s41392-026-02662-z](https://doi.org/10.1038/s41392-026-02662-z)

   > Therapeutic strategies targeting aging hallmarks can delay aging and mitigate disease risk. The convergence of AI, multitarget strategies, and precision medicine signals a transformative era in extending healthspan and combating aging-associated diseases.

## Structured data

```json
{"@context":"https://schema.org","@graph":[{"@type":"MedicalWebPage","@id":"https://magellanlongevity.com/study/aging_therapeutics_2026.html#page","url":"https://magellanlongevity.com/study/aging_therapeutics_2026.html","name":"Insights into the therapeutic strategies for aging and aging-associated diseases","description":"A 2026 map of the longevity-therapeutics field: senolytics, senomorphics, senoreversion and caloric-restriction mimetics are the leading strategies, with…","inLanguage":"en","isPartOf":{"@type":"WebSite","name":"Magellan Longevity","url":"https://magellanlongevity.com/"},"author":{"@type":"Person","name":"Gabriel Radu, DO","jobTitle":"Physiatrist (PM&R)","identifier":[{"@type":"PropertyValue","name":"NPI","value":"1376861765"},{"@type":"PropertyValue","name":"NY medical license","value":"275110"}]},"publisher":{"@type":"Organization","name":"Magellan Longevity","url":"https://magellanlongevity.com/"},"encoding":{"@type":"MediaObject","encodingFormat":"text/markdown","contentUrl":"https://magellanlongevity.com/study/aging_therapeutics_2026.md"},"dateModified":"2026-09-02"},{"@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://magellanlongevity.com/"},{"@type":"ListItem","position":2,"name":"Research map","item":"https://magellanlongevity.com/longevity-research-map.html"},{"@type":"ListItem","position":3,"name":"Insights into the therapeutic strategies for aging and…","item":"https://magellanlongevity.com/study/aging_therapeutics_2026.html"}]},{"@type":"ScholarlyArticle","@id":"https://magellanlongevity.com/study/aging_therapeutics_2026.html#study","name":"Insights into the therapeutic strategies for aging and aging-associated diseases","headline":"Insights into the therapeutic strategies for aging and aging-associated diseases","datePublished":"2026","isPartOf":{"@type":"Periodical","name":"Signal Transduction and Targeted Therapy"},"identifier":"PMID:42225652","url":"https://pubmed.ncbi.nlm.nih.gov/42225652/","sameAs":"https://doi.org/10.1038/s41392-026-02662-z","abstract":"A 2026 map of the longevity-therapeutics field: senolytics, senomorphics, senoreversion and caloric-restriction mimetics are the leading strategies, with AI accelerating discovery — but human proof remains the gating step."}]}
```

## Related on Magellan Longevity

- [Longevity research map](https://magellanlongevity.com/longevity-research-map.html)
- [Evidence-based longevity supplements](https://magellanlongevity.com/longevity-supplements.md)

## Scope and disclosures

Educational information, not medical advice. Nothing here is intended to diagnose, treat, cure, or prevent any disease. Talk to your physician before starting any supplement or device, especially if you are pregnant, nursing, or taking medication.

Editorial firewall: evidence grades are assigned from the published research and are independent of any affiliate commission. As an Amazon Associate, Magellan Longevity earns from qualifying purchases.

Reviewed for accuracy by a board-certified physician (DO).